Ampersand, digital health therapies provider for inflammatory conditions, has partnered with Simplyhealth and received investment from the health solutions company, to increase the roll out of digital therapeutics across the UK.
The investment by Simplyhealth aims to help reduce outpatient appointments, improve health outcomes, and reduce unplanned hospital visits for patients suffering with inflammatory conditions. Ampersand provides digital health tools for clinicians and patients to better manage and monitor chronic, inflammatory diseases which includes Crohn's, arthritis and psoriasis. The provider works in conjunction with scientists, clinicians, and NHS Trusts, to implement behavioural science-based interventions as well as "hospital at home" pathways. Ampersand's technology was developed in partners...
To continue reading this article...
Join COVER for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, key trend analysis and industry insights.
- Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
- Receive breaking news stories straight to your inbox in the daily newsletter.
- Members only access to monthly programme 'The COVER Review'
- Be the first to hear about our CPD accredited events and awards programmes.
